BNTX (BioNTech) Technical Analysis

BNTX Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
BNTX
BNTX

BioNTech

$92.83+0.11%
Today's High$93.77
Today's Low$91.00
Today's Open$92.72
Yesterday's Close$92.72

BNTX (BioNTech) Technical Analysis Overview

AI CreationAs of June 30, 2026, BioNTech (BNTX) is showing range-bound consolidation with short-term bullish signals beneath longer-term overhead resistance. The MACD Level at 0.0212 carries a Buy signal, indicating a golden cross formation and positive momentum development, while the RSI(14) reading of 55.7715 reflects neutral equilibrium leaning slightly toward strength. The Momentum(10) at 2.57 with a Buy signal reinforces the near-term constructive bias. The short-term moving average system—EMA10 at 91.4836 and SMA20 at 89.8385 in Buy alignment—confirms support structure, though the longer-term framework remains challenged, with EMA50 at 92.6108 and SMA200 at 99.1274 both in Sell territory, indicating that any rally remains constrained within a bear-market bounce rather than a genuine reversal.

Oscillators

Strong Sell
Strong Buy
Neutral
2
Sell
7
Neutral
2
Buy

Summary

Strong Sell
Strong Buy
Neutral
8
Sell
8
Neutral
10
Buy

Moving Averages

Strong Sell
Strong Buy
Buy
6
Sell
1
Neutral
8
Buy

BNTX (BioNTech) Live Candlestick Chart

BNTX (BioNTech) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)9510486311
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)54.057.454.346.6
MACD (12,26)Golden CrossGolden CrossGolden CrossDeath Cross

BNTX (BioNTech) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
54.3566Neutral
Stochastic %K (14, 3, 3)
84.655Neutral
Commodity Channel Index (CCI) (20)
125.7885Sell
Average Directional Index (ADX) (14)
10.4316Neutral
Awesome Oscillator (AO)
1.3929Neutral
Momentum Indicator (10)
3.385Buy
MACD Level (12, 26)
0.1264Buy
Stochastic RSI Fast (3, 3, 14, 14)
83.3377Sell
Williams Percent Range (%R) (14)
-24.5526Neutral
Bull Bear Power (BBP)
3.6255Neutral
Ultimate Oscillator (UO) (7, 14, 28)
53.4945Neutral

Moving Averages

NameValueOperation
EMA (10)
91.6908Buy
SMA (10)
91.5545Buy
EMA (20)
91.2479Buy
SMA (20)
90.0098Buy
EMA (30)
91.5335Buy
SMA (30)
90.5632Buy
EMA (50)
92.6095Buy
SMA (50)
93.6334Sell
EMA (100)
95.1354Sell
SMA (100)
95.9854Sell
EMA (200)
98.1846Sell
SMA (200)
99.1065Sell
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
91.1975Neutral
Volume-Weighted Moving Average (VWMA) (20)
89.6732Buy
Hull Moving Average (HMA) (9)
93.751Sell

BNTX (BioNTech) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R3116.785104.396.4834112.0175-
R2104.399.530795.3389104.7288-
R198.67596.584394.194599.532595.245
Pivot P91.81591.81591.81592.243890.1
S186.1987.045791.905587.047582.76
S279.3384.099390.761179.7588-
S366.84579.3389.616674.5625-

BNTX (BioNTech) Market Sentiment Index

Analyst Rating121.5465
Options Put/Call Ratio+51.89%
Implied Volatility (IV)41.8198

BNTX (BioNTech) Deep Technical Analysis

As of June 30, 2026, BioNTech (BNTX) is exhibiting a range-bound technical structure with short-term bullish momentum emerging beneath longer-term overhead resistance. The MACD Level of 0.0212 carries a Buy signal, indicating a golden cross formation and positive momentum development; this suggests buyers are gaining traction even as the indicator sits just above the zero line. The RSI(14) at 55.7715 sits in the strong zone (55–70), reflecting constructive power between bulls and bears with a slight bullish lean, implying the current move remains supported but has not yet reached exhaustion. The **BNTX technical analysis** framework shows that the Momentum(10) reading of 2.57 with a Buy signal aligns with the MACD and RSI, reinforcing conviction in the short-term upside bias. The Average Directional Index (14) at 10.0043 with a Neutral signal indicates a weak trend environment, suggesting the market is more prone to oscillation and range-bound behavior than sustained directional movement. The Commodity Channel Index (20) at 174.4812 also carries a Neutral signal, confirming that neither overbought nor oversold extremes are present, which aligns with the RSI reading and suggests the current structure remains exploratory rather than exhausted. The moving average system reveals a constructive short-term setup with conflicting medium-to-longer-term signals. EMA10 at 91.4836 and SMA20 at 89.8385 sit in close proximity and provide near-term support, confirming bullish alignment in the short term. However, EMA50 at 92.6108 and SMA200 at 99.1274, both carrying Sell signals, tower above the current price near 93.30 and act as significant overhead resistance, indicating that the broader trend remains bearish and any rally faces substantial structural headwinds. This divergence suggests the near-term BNTX price forecast is constrained within a bear-market bounce rather than a genuine reversal. In terms of key levels, the Fibonacci retracement structure provides reference points for the current price action. Resistance targets lie at R1 (99.4071), R2 (102.3996), and R3 (107.2433), with the pivot at 94.5633 acting as a mid-point. Support levels are anchored at S1 (89.7196), S2 (86.7271), and S3 (81.8833). The current price of 93.30 sits near the pivot zone, suggesting the BNTX market analysis remains focused on consolidation within the 89–95 range before any meaningful upside extension becomes probable. The recent daily range (high 94.96, low 91.11) confirms that price is consolidating within a narrow band, consistent with the weak ADX reading and the overall range-bound structure. On the market breadth front, the implied volatility reading of 47.5163 indicates moderate-to-elevated option pricing, suggesting traders are pricing in meaningful uncertainty and potential for price swings. The option Put/Call ratio of 14.29 reflects elevated hedging demand with a bias toward put positioning, indicating heightened risk aversion and defensive positioning despite the mixed technical signals. The analyst rating of 121.9073 reflects an overall positive bias from the research community, which provides a contrarian note to the technical structure and may offer support to any dip toward the moving average support zone. This combination suggests that while the near-term BNTX price prediction leans toward consolidation and potential bounce, the longer-term technical setup remains challenged by the downtrend defined by the EMA50 and SMA200.

FAQ

What is the current technical rating for BNTX?

x
On the 4H timeframe, the aggregate technical rating for BNTX is Neutral. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for BNTX?

x

What are the current RSI and MACD signals for BNTX?

x

How often is the BNTX technical analysis data updated?

x

Continue Exploring BNTX (BioNTech)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.